Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA known ✓ | P10253 | 2/20 | 0.45 |
| ▸ | HSP90AA1 known ✓ | P07900 | 1/20 | 0.42 |
| ▸ | RET known ✓ | P07949 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.95 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.95 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.95 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.95 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.95 |
| ▸ | TSHR | P16473 | 2/20 | 0.95 |
| ▸ | GFER | P55789 | 2/20 | 0.95 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.95 |
| ▸ | RECQL | P46063 | 1/20 | 0.95 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.52 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.52 |
| ▸ | S100B | P04271 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | ESRRG | P62508 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL970321 | 1.00 | ALDH1A1 (0.95) | ALDH1A1L3MBTL1CYP3A4TDP1MAPK1 | |
| SCHEMBL8467252 | 0.97 | ALDH1A1 (1.00) | ALDH1A1L3MBTL1CYP3A4TDP1MAPK1 | |
| SCHEMBL33781 | 0.97 | ALDH1A1 (1.00) | ALDH1A1L3MBTL1CYP3A4TDP1MAPK1 | |
| Hydrochloric Acid SCHEMBL7752117 | 0.93 | ALDH1A1 (0.91) | ALDH1A1L3MBTL1CYP3A4TDP1MAPK1 | |
| Potassium Iodide SCHEMBL28933576 | 0.91 | ALDH1A1 (0.86) | ALDH1A1L3MBTL1CYP3A4TDP1MAPK1 | |
| Iodide SCHEMBL5069469 | 0.91 | ALDH1A1 (0.86) | ALDH1A1L3MBTL1CYP3A4TDP1MAPK1 | |
| SCHEMBL2155334 | 0.91 | ALDH1A1 (0.86) | ALDH1A1L3MBTL1CYP3A4TDP1MAPK1 | |
| 4-Aminophenol SCHEMBL11496760 | 0.89 | ALDH1A1 (0.76) | ALDH1A1L3MBTL1CYP3A4TDP1MAPK1 | |
| Sulfur Dioxide SCHEMBL6515046 | 0.89 | ALDH1A1 (0.83) | ALDH1A1L3MBTL1CYP3A4TDP1MAPK1 | |
| SCHEMBL8715756 | 0.89 | ALDH1A1 (0.83) | ALDH1A1L3MBTL1CYP3A4TDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5182213-A | Coupling a Phenylenediamine and a Naphthol | MILES INC. (US) | 1993-01-26 | — | — | US | claimed |
| EP-0504663-A1 | Peroxidase indicator system for basic media | Bayer Corporation (US) | 1992-09-23 | — | — | EP | claimed |
| US-20250143296-A1 | METHOD FOR INACTIVATING VIRUSES OR BACTERIA | KAO CORPORATION (JP) | 2025-05-08 | — | — | US | disclosed |
| US-20250143295-A1 | VIRAL OR BACTERIAL INACTIVATION AGENT COMPOSITION | KAO CORPORATION (JP) | 2025-05-08 | — | — | US | disclosed |
| EP-4473834-A1 | METHOD FOR INACTIVATING VIRUS OR BACTERIUM | Kao Corporation (JP) | 2024-12-11 | — | — | EP | disclosed |
| EP-4473835-A1 | COMPOSITION FOR INACTIVATING VIRUS OR BACTERIUM | Kao Corporation (JP) | 2024-12-11 | — | — | EP | disclosed |
| CN-118890962-A | Method for inactivating viruses or bacteria | 花王株式会社 | 2024-11-01 | — | — | CN | disclosed |
| CN-118647269-A | Virus or fungus inactivating agent composition | 花王株式会社 | 2024-09-13 | — | — | CN | disclosed |
| WO-2023145559-A1 | METHOD FOR INACTIVATING VIRUS OR BACTERIUM | 花王株式会社 | 2023-08-03 | — | — | WO | disclosed |
| WO-2023145560-A1 | COMPOSITION FOR INACTIVATING VIRUS OR BACTERIUM | 花王株式会社 | 2023-08-03 | — | — | WO | disclosed |
| US-11116772-B2 | Medical methods utilising high purity diaminophenothiazinium compounds | WISTA LABORATORIES LTD. (SG) | 2021-09-14 | — | — | US | disclosed |
| US-5132429-A | BENZOTRIAZOLE DERIVATIVES AND FLUORESCENCE-EMITTING REAGENTS THEREOF | SHIONOGI & CO., LTD. (JP) | 1992-07-21 | — | — | US | disclosed |
| US-RE33635-E | Enzymatic assay method | TOYO JOZO KABUSHIKI KAISHA (JP) | 1991-07-09 | — | — | US | disclosed |
| EP-0418386-A1 | BENZOTRIAZOLE DERIVATIVES AND FLUORESCENCE-EMITTING REAGENTS CONTAINING THEM | SHIONOGI & CO., LTD. (JP) | 1991-03-27 | — | — | EP | disclosed |
| EP-0364845-A2 | Photographic-reversal process | Agfa-Gevaert AG (DE) | 1990-04-25 | — | — | EP | disclosed |
| EP-0243126-A2 | Method of measuring hydrogen peroxide or of measuring an enzyme or biochemical substrate liberating the peroxide | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 1987-10-28 | — | — | EP | disclosed |
| EP-0243125-A2 | Method of measuring phenol and alpha-naphthol, and method of measuring the activity of enzymes | SANWA KAGAKU KENKYUSHO CO., LTD. (JP) | 1987-10-28 | — | — | EP | disclosed |
| US-4681841-A | CONSUMING OXYGEN OR GENERATING A PIGMENT; MEASUREMENT BY AN OXYGEN ELECTRODE OR COLORIMETRIC ASSAY | TOYO JOZO KABUSHIKI KAISHA (JP) | 1987-07-21 | — | — | US | disclosed |
| US-4675290-A | CHROMATOGRAPHY OF THE ANILINE DYE PRODUCED BY COUPLING REACTI ON OF THE AMINE FORMED FROM THE AMIDE SUBSTRATE | TOYO JOZO KABUSHIKI KAISHA (JP) | 1987-06-23 | — | — | US | disclosed |
| US-4588836-A | LEUCYL- OR GLUTAMYL-3,5-DIHALO-4-HYDROXYANILIDES | TOYO JOZO KABUSHIKI KAISHA (JP) | 1986-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11116772-B2 | Medical methods utilising high purity diaminophenothiazinium compounds | MGMT, MAPT, TST | GAA 822/4885HSP90AA1 4749/4885RET 18/4885 |
| US-20250143295-A1 | VIRAL OR BACTERIAL INACTIVATION AGENT COMPOSITION | POLL, POLI, POLB | GAA 1017/4885HSP90AA1 803/4885RET 3891/4885 |
| US-20250143296-A1 | METHOD FOR INACTIVATING VIRUSES OR BACTERIA | POLI, POLL, POLB | GAA 1495/4885HSP90AA1 3300/4885RET 3940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.